Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2003
11/27/2003WO2002094881A3 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/27/2003WO2002094195A3 Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents
11/27/2003WO2002092771A3 Specific binding proteins and uses thereof
11/27/2003WO2002089737A3 Separation of platelets from whole blood for use as a healant
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002086113A3 Enzyme and snp marker for disease
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003WO2002083731A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/27/2003WO2002081490A3 Computer-directed assembly of a polynucleotide encoding a target polypeptide
11/27/2003WO2002077272A3 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
11/27/2003WO2002072632A3 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
11/27/2003WO2002070006A8 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
11/27/2003WO2002068962A3 Determining cartilage degeneration and aging using bone morphogenic proteins
11/27/2003WO2002066617A8 Method for detecting a risk of hypertension and uses thereof
11/27/2003WO2002064825A3 Microelectronic array devices to perform multiplex immunoassay analysis
11/27/2003WO2002064791A3 Proteins and nucleic acids encoding same
11/27/2003WO2002062302A3 Steroidal derivatives
11/27/2003WO2002061428A8 Method of disrupting interactions between biotin and biotin-binding compounds
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003WO2002059603A3 Microdevices containing photorecognizable coding patterns and methods of using and producing the same thereof
11/27/2003WO2002057788A3 Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone
11/27/2003WO2002057499A3 Mdr1 variants and methods for their use
11/27/2003WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/27/2003WO2002048368A3 Proteins associated with cell growth, differentiation, and death
11/27/2003WO2002029087A3 Use of lymphangiogenic agents to treat lymphatic disorders
11/27/2003WO2001058926A3 Protein mapping
11/27/2003WO2000062735A3 Treatment of neoplasms with viruses
11/27/2003US20030221223 Producing genetically engineerered human blood protein such as hemoglobin, antitrypsin, fibrinogen and thrombin in monocot plant seed; veterinary medicine
11/27/2003US20030221215 Comprises nucleotide sequences for preventing oomycete infection of potato and/or tomato; disease resistant plants
11/27/2003US20030221205 Olfactory and pheromones G-protein coupled receptors
11/27/2003US20030220777 Method and system for determining genotype from phenotype
11/27/2003US20030220748 Computer-aided techniques for analyzing biological sequences
11/27/2003US20030220746 Method and system for computing and applying a global, multi-channel background correction to a feature-based data set obtained from scanning a molecular array
11/27/2003US20030220583 Portable diagnostic system
11/27/2003US20030220502 A low molecular weight cyanine dye complexes, absorption spectra
11/27/2003US20030220489 29 human secreted proteins
11/27/2003US20030220484 Modified ciliary neurotrophic factors
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
11/27/2003US20030220481 Liquid comprising receptor interacting protein death domain (RIP DD) for use as tool in discovery of antagonist of tumor necrosis factor signaling pathway
11/27/2003US20030220473 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein
11/27/2003US20030220471 Extracellular proteins coded by nucleic acids, receptor or membrane-bound proteins, amino acid sequence lacking the signal peptide; use as drugs as thrombolytic agents, interferons, interleukins, erythropoietins
11/27/2003US20030220470 Methods for the purification of stable radioiodine conjugates
11/27/2003US20030220316 Such as N-(1-(1-methylethyl)piperidin-4-yl)-N-((4-methyl phenyl)methyl)-4-methoxyphenylacetamide for stimulation of serotonin receptors
11/27/2003US20030220306 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
11/27/2003US20030220281 To inhibit the activity of elastase or cathepsin G, thereby inhibiting ectopic implantation of endometrial fragments.
11/27/2003US20030220246 Novel FGF homolog zFGF11
11/27/2003US20030220239 Epitope sequences
11/27/2003US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder
11/27/2003US20030220229 Modulate an immunological response by T cells of Type I diabetics which can be used as an indicator; derived from a region of proinsulin that spans the junction between the B chain and C peptide; inhibiting the development/progression
11/27/2003US20030219910 Immunoassay method/equipment, biological component measurable toilet, anti-albumin monoclonal antibody, cell strain producing the same, and albumin detection kit
11/27/2003US20030219908 An analytical test device for a competition binding, pregnancy testing; comprising a dry porous carrier for applying a liquid sample onto
11/27/2003US20030219907 A controller for gas apparatus, monitoring the concentration of each components, comparing with the setpoint of the gas, displaying the readout
11/27/2003US20030219905 Preparing sample for analysis, by breaking down protein in sample with enzyme solution to form peptides; purification
11/27/2003US20030219904 Evaluating a platelet therapy by testing blood sample; anticoagulants
11/27/2003US20030219893 Compositions and methods for the treatment of hepatitis C virus infection
11/27/2003US20030219892 Illuminating the cells to obtain an image, determining the locations of specific individual cells, using energy beam to induce a response; detection, for drug delivery of genes into specific cells of interest
11/27/2003US20030219891 An biological, optic apparatus for gene testing, optical sensor comprising pixels for detecting chemiluminescence between the reaction of biological sample and a reagent
11/27/2003US20030219888 Binding enzyme, toxin with inorganic catalyst or fusion proteins which are contained in achromobacter cells, for using diagnositic, therapeutic, and drug screening
11/27/2003US20030219885 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2003US20030219884 Using laser beams to monitor and measuring electrical potential across transport/membrane proteins and/or g-protein coupled receptors; drug screening
11/27/2003US20030219876 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
11/27/2003US20030219874 Comprises endothelial differentiation gene receptor proteins (EDG8) for monitoring receptivity to and/or diagnosing cancer, angiogenesis and inflammation
11/27/2003US20030219873 Self-assembling recombinant papillomavirus capsid proteins
11/27/2003US20030219860 Comprises nucleotide sequences coding novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents
11/27/2003US20030219850 Method for automatically analyzing nucleated bone marrow cells
11/27/2003US20030219849 Fluorescent phospholipase assay, phospholipase A2 inhibitor and stimulator, and the use thereof
11/27/2003US20030219848 Comprises beta-galactosidase fragments for use as diagnostic tools in monitoring intracellular events; protein folding and solubility analysis
11/27/2003US20030219845 Immunoassay for F1.2 prothrombin fragment
11/27/2003US20030219844 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein
11/27/2003US20030219843 Methods of diagnosing and treating abnormal growth
11/27/2003US20030219842 Assays for cancer patient monitoring based on levels of epidermal growth factor receptor (EGFR) extracellular domain (ECD) analyte, alone or in combination with other analytes, in body fluid samples
11/27/2003US20030219841 Method and reagent for the detection of apoptotic cells and of a protease activated during apoptosis
11/27/2003US20030219840 Detecting or identifying proteins which can be used as diagnostic markers for prostate cancer proteins
11/27/2003US20030219838 Polypeptide analyses using stable isotope labeling
11/27/2003US20030219837 Integrin ligand
11/27/2003US20030219836 Prognosticating probability of pregnancy via selectin concentration; in vitro fertilization
11/27/2003US20030219835 Using cd antigen 16b to diagnose urogenital disorders
11/27/2003US20030219833 Assay devices and methods of analyte detection
11/27/2003US20030219832 Administered or coadministered with retinoid drugs to prevent or ameliorate toxicity or side effects caused by retinoids or vitamin A or vitamin A precursors
11/27/2003US20030219831 Split-hybrid system
11/27/2003US20030219827 Comprises immunoglobulins which bind FMS-related tyrosine kinase 3 (Flt3) receptor for diagnosis and treatment of cancer; immunotherapy
11/27/2003US20030219826 Comprises amino acid sequence for treating arthritic, inflammatory and apoptosis disorders; mimetics
11/27/2003US20030219825 High throughput method for screening candidate compounds for biological activity
11/27/2003US20030219824 High throughput screening method and apparatus
11/27/2003US20030219822 Biosensor and method
11/27/2003US20030219820 Using differential scanning calorimetry to monitor hydrophobic, covalent, ionic, or hydrogen bonding interactions associated with proteins and/or polynucleotides under heated conditions; high throughput assay
11/27/2003US20030219818 Evaluating patient response to antiproliferative/antitumor agents; immunotherapy
11/27/2003US20030219817 Preparing and screening immunoglobulin libraries; analyzing binding activity of affinity pairs; mimetic for treatment of autoimmune, cancer, viral and asthma disorders
11/27/2003US20030219816 Composite microarray slides
11/27/2003US20030219812 Methods and devices for obtaining and assaying mammary fluid samples for evaluating breast diseases, including cancer
11/27/2003US20030219811 Comprises nucleotide sequences for diagnosing tuberculosis infection and mycobacterial infections
11/27/2003US20030219802 Diagnosis and treatment of osteosarcoma
11/27/2003US20030219800 Preparing transgenic cells using microarrays comprised of positionally fixed nucleic acids; genetic engineering; high-throughput assay
11/27/2003US20030219797 Statistical modeling to analyze large data arrays
11/27/2003US20030219796 Method of testing for allergic disease
11/27/2003US20030219795 Identifying modulators of tumor suppressor genes; antitumor/antiproliferative/anticarcinogenic agents
11/27/2003US20030219789 36P6D5: secreted tumor antigen
11/27/2003US20030219784 Using nucleic acid based bioassay to determine quality of grains
11/27/2003US20030219782 Identifying agents which modulate sphingolipid metabolism; drug screening; antiproliferative agents; diagnosing muscular and cancer disorders
11/27/2003US20030219780 Methods for the preparation of chemically misaminoacylated tRNA via protective groups